{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:04:14Z","timestamp":1789621454600,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Brazilian Diabetes Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hypoglycemia is a barrier to optimal glucose control in the treatment of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Blood glucose monitoring is essential in diabetes management. Inappropriate glucose management is associated with high mortality and morbidity. FreeStyle Libre\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (FSL) is a continuous glucose monitoring (CGM) system that provides effective, safe, and convenient glucose monitoring, without routine finger pricking. This study aims to estimate the incremental cost-effectiveness ratio (ICER) of the FSL system in comparison to conventional Self-monitoring of blood glucose (SMBG) in T1DM and T2DM patients that require intensive insulin therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A decision-tree model was developed to compare the cost-effectiveness ratio between FSL and conventional SMBG from the perspective of the Brazilian Public Healthcare System (SUS). The model captures the cumulative rates of acute complications such as severe hypoglicemia and diabetic ketoacidosis, per-event costs, and quality-adjusted life-years (QALYs) gained over a 1-year time horizon in adult and pediatric patients (\u2265\u20094 years old) with T1DM or T2DM. Inputs from the Brazilian health databases, clinical trials, and real-world data were used in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results demonstrated that, regarding solely severe hypoglicemia and diabetic ketoacidosis events, T1DM have a QALY difference of 0.276, a cost difference of R$ 7.255, and an ICER of R$ 26,267.69 per QALY gained for CGM with FSL, when compared to conventional SMBG. T2DM results demonstrated equally a QALY difference of 0.184, a cost difference of R$ 7290, and an ICER of R$ 39,692.67 per QALY gained, in favour of CGM with FSL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrated that FSL is cost-effective in T1DM and T2DM for acute diabetic complications, from a SUS perspective. CGM with FSL can promote safe, convenient, and cost-effective glucose monitoring, therefore contributing to the improvement of the incidence of complications and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-023-01208-5","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T21:02:13Z","timestamp":1700859733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre\u00ae in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitus"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-5967","authenticated-orcid":false,"given":"Luciana","family":"Bahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0096-2325","authenticated-orcid":false,"given":"Karla F.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8921-515X","authenticated-orcid":false,"given":"L\u00edvia Lovato Pires","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-2668","authenticated-orcid":false,"given":"Naiane Lima","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6447-7512","authenticated-orcid":false,"given":"Eduardo","family":"Mulinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-5983","authenticated-orcid":false,"given":"Domingos A.","family":"Malerbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"issue":"4","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/dme.12844","volume":"33","author":"SR Heller","year":"2016","unstructured":"Heller SR, Frier BM, Hersl\u00f8v ML, Gundgaard J, Gough SCL. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med (Internet). 2016;33(4):471\u20137. https:\/\/doi.org\/10.1111\/dme.12844.","journal-title":"Diabet Med (Internet)"},{"key":"1208_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1742-1241.2009.02176.x","volume":"63","author":"T Kunt","year":"2009","unstructured":"Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract (Internet). 2009;63:6\u201310. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02176.x.","journal-title":"Int J Clin Pract (Internet)."},{"issue":"6","key":"1208_CR3","first-page":"287","volume":"70","author":"J Hortensius","year":"2012","unstructured":"Hortensius J, Kleefstra N, Houweling ST, van der Bijl JJ, Gans RO, Bilo HJ. What do professionals recommend regarding the frequency of self-monitoring of blood glucose? Neth J Med. 2012;70(6):287\u201391.","journal-title":"Neth J Med"},{"issue":"5","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3949\/ccjm.83a.14147","volume":"83","author":"S Knapp","year":"2016","unstructured":"Knapp S, Manroa P, Doshi K. Self-monitoring of blood glucose: advice for providers and patients. Cleve Clin J Med. 2016;83(5):355\u201360.","journal-title":"Cleve Clin J Med"},{"key":"1208_CR5","unstructured":"da Brasil MS. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas do Diabete Melito Tipo 2; 2020."},{"issue":"12","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1111\/jan.14190","volume":"75","author":"V Mogre","year":"2019","unstructured":"Mogre V, Johnson NA, Tzelepis F, Shaw JE, Paul C. A systematic review of adherence to diabetes self-care behaviours: evidence from low- and middle-income countries. J Adv Nurs. 2019;75(12):3374\u201389.","journal-title":"J Adv Nurs"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13098-018-0379-5","volume":"10","author":"RNN Lamounier","year":"2018","unstructured":"Lamounier RNN, Geloneze B, Leite SOO, Montenegro R, Zajdenverg L, Fernandes M, et al. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil. Diabetol Metab Syndr (Internet). 2018;10(1):83. https:\/\/doi.org\/10.1186\/s13098-018-0379-5.","journal-title":"Diabetol Metab Syndr (Internet)"},{"key":"1208_CR8","unstructured":"FreeStyle Libre\u2014Sistema Flash de Monitoramento de Glicose. Dispon\u00edvel em: <https:\/\/www.freestylelibre.com.br\/index.html>. Acesso em 13 de maio de 2020. 2020."},{"key":"1208_CR9","first-page":"1","volume":"2020","author":"J Unger","year":"2020","unstructured":"Unger J, Kushner P, Anderson JE. Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care. Postgr Med. 2020;2020:1.","journal-title":"Postgr Med"},{"issue":"1","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/17446651.2020.1706482","volume":"15","author":"JY Stone","year":"2020","unstructured":"Stone JY, Bailey TS. Benefits and limitations of continuous glucose monitoring in type 1 diabetes. Expert Rev Endocrinol Metab. 2020;15(1):41\u20139.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1208_CR11","first-page":"1","volume":"2016","author":"E Palylyk-Colwell","year":"2016","unstructured":"Palylyk-Colwell E, Ford C. Flash glucose monitoring system for diabetes. CADTH Issues Emerg Health Technol. 2016;2016:1.","journal-title":"CADTH Issues Emerg Health Technol"},{"issue":"8","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu10080992","volume":"10","author":"G Mancini","year":"2018","unstructured":"Mancini G, Berioli MG, Santi E, Rogari F, Toni G, Tascini G, et al. Flash glucose monitoring: a review of the literature with a special focus on type 1 diabetes. Nutrients. 2018;10(8):1.","journal-title":"Nutrients"},{"issue":"1","key":"1208_CR13","first-page":"155","volume":"14","author":"A Chico","year":"2020","unstructured":"Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernandez R, Escalada FJ, et al. Clinical Approach to flash glucose monitoring: an expert recommendation. BMC Endocr Disord. 2020;14(1):155\u201364.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/dme.13584","volume":"35","author":"L Leelarathna","year":"2018","unstructured":"Leelarathna L, Wilmot EG. Flash forward: a review of flash glucose monitoring. Diabet Med. 2018;35(4):472\u201382.","journal-title":"Diabet Med"},{"issue":"1","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.diabet.2017.10.009","volume":"44","author":"S Borot","year":"2018","unstructured":"Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, et al. Practical implementation, education and interpretation guidelines for continuous glucose monitoring: a French position statement. Diabetes Metab. 2018;44(1):61\u201372.","journal-title":"Diabetes Metab"},{"key":"1208_CR16","unstructured":"CADTH. Flash glucose monitoring system FreeStyle Libre to monitor glycemia in patients with diabetes; 2020. p. undefined-51."},{"issue":"266","key":"1208_CR17","first-page":"23","volume":"2022","author":"R Poole","year":"1861","unstructured":"Poole R. Diagnosis and management of type 1 diabetes in adults. Practitioner. 1861;2022(266):23\u20136.","journal-title":"Practitioner"},{"key":"1208_CR18","unstructured":"NICE Guidelines. Recommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE. NICE Guidel. 2022(June):1\u201368."},{"issue":"30","key":"1208_CR19","first-page":"67","volume":"20","author":"A Martyn","year":"2006","unstructured":"Martyn A. Type 2 diabetes in adults. Nurs Stand. 2006;20(30):67.","journal-title":"Nurs Stand"},{"key":"1208_CR20","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Secretaria de Ci\u00eancia-Tecnologia e Insumos Estrat\u00e9gicos. Departamento de Ci\u00eancia e Teccnologia. Diretrizes metodol\u00f3gicas: estudos de avalia\u00e7\u00e3o econ\u00f4mica de tecnologias em sa\u00fade. 2nd ed. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2014. p. 132."},{"key":"1208_CR21","unstructured":"York Health Economics Consortium. Incremental Cost-Effectiveness Ratio (ICER). 2023; Available from: https:\/\/yhec.co.uk\/glossary\/incremental-cost-effectiveness-ratio-icer\/."},{"key":"1208_CR22","doi-asserted-by":"crossref","unstructured":"Shafrin J, May S, Skornicki M, Hathway J, Macaulay R, Villeneuve J, et al. Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments. Value Heal [Internet]. 2016;19(7):A731. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301516335689.","DOI":"10.1016\/j.jval.2016.09.2202"},{"key":"1208_CR23","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas de Diabetes Melito Tipo 1. 2019; Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/protocolos\/portaria-conjunta-pcdt-diabete-melito-1.pdf."},{"issue":"10057","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1208_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-PP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther (Internet). 2017;8(1):55\u201373. https:\/\/doi.org\/10.1007\/s13300-016-0223-6.","journal-title":"Diabetes Ther (Internet)"},{"key":"1208_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.diabres.2018.01.028","volume":"138","author":"R Hellmund","year":"2018","unstructured":"Hellmund R, Weitgasser R, Blissett D. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment. Diabetes Res Clin Pr. 2018;138:193\u2013200.","journal-title":"Diabetes Res Clin Pr"},{"issue":"1","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2018.0362","volume":"21","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C. The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. Diabetes Technol Ther. 2019;21(1):1\u20135.","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement 1","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"68-OR","DOI":"10.2337\/db20-68-OR","volume":"69","author":"R Roussel","year":"2020","unstructured":"Roussel R, Guerci B, Vicaut E, Depouvourville G, Detournay B, Emery C, et al. 68-OR: dramatic drop in ketoacidosis rate after freestyle libre system initiation in type 1 and type 2 diabetes in france, especially in people with low self-monitoring of blood glucose (SMBG): a nationwide study. Diabetes. 2020;69(Supplement 1):68-OR.","journal-title":"Diabetes"},{"issue":"1","key":"1208_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13098-017-0206-4","volume":"9","author":"L Bahia","year":"2017","unstructured":"Bahia L, Kupfer R, Momesso D, Cabral DAP, Tschiedel B, Pu\u00f1ales M, et al. Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study. Diabetol Metab Syndr. 2017;9(1):9.","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"1208_CR30","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s11136-014-0712-x","volume":"23","author":"JT Lauridsen","year":"2014","unstructured":"Lauridsen JT, L\u00f8nborg J, Gundgaard J, Jensen HH. Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2014;23(9):2645\u201350.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"3","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jval.2016.10.007","volume":"20","author":"LS Matza","year":"2017","unstructured":"Matza LS, Stewart KD, Davies EW, Hellmund R, Polonsky WH, Kerr D. Health state utilities associated with glucose monitoring devices. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2017;20(3):507\u201311.","journal-title":"Value Heal J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"1208_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1477-7525-11-90","volume":"11","author":"M Evans","year":"2013","unstructured":"Evans M, Khunti K, Mamdani M, Galbo-J\u00f8rgensen CB, Gundgaard J, B\u00f8gelund M, et al. Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes. 2013;11:90.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1177\/0272989X16658660","volume":"36","author":"T Peasgood","year":"2016","unstructured":"Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making. 2016;36(8):1020\u201333.","journal-title":"Med Decis Making"},{"key":"1208_CR34","unstructured":"Sociedade Brasileira de Diabetes (SBD). Diretrizes Sociedade Brasileira de Diabetes 2019\u20132020. Available on: <https:\/\/www.diabetes.org.br\/profissionais\/images\/banners\/Diretrizes_SBD_2020_04FEV20.pdf>. 1 Mar 2023; 2020."},{"key":"1208_CR35","unstructured":"Banco de Pre\u00e7os em Sa\u00fade. C\u00f3digo do CATMAT: BR0389555; Compras de 2022; 2023."},{"key":"1208_CR36","unstructured":"Banco de Pre\u00e7os em Sa\u00fade. C\u00f3digo do CATMAT: BR0339565; Compras de 2022; 2023."},{"key":"1208_CR37","unstructured":"Banco de Pre\u00e7os em Sa\u00fade. C\u00f3digo do CATMAT: BR0338605; Compras de 2022; 2023."},{"key":"1208_CR38","unstructured":"BRASIL.Minist\u00e9rio da Sa\u00fade. Departamento de Inform\u00e1tica do Sistema \u00danico de Sa\u00fade (DATASUS); 2022."},{"issue":"1","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"001330","DOI":"10.1136\/bmjdrc-2020-001330","volume":"8","author":"I Oyag\u00fcez","year":"2020","unstructured":"Oyag\u00fcez I, Merino-Torres JF, Brito M, Bellido V, Cardona-Hernandez R, Gomez-Peralta F, et al. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care (Internet). 2020;8(1):001330. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001330.","journal-title":"BMJ Open Diabetes Res Care (Internet)"},{"issue":"9","key":"1208_CR40","doi-asserted-by":"publisher","first-page":"PA920","DOI":"10.1016\/j.jval.2017.08.2870","volume":"20","author":"R Lamounier","year":"2017","unstructured":"Lamounier R, Ermetice M, Griciunas F, Silva C. Costs of managing hypoglycaemias among insulin-treated patients with diabetes: results from the hat study in Brazil. Value Heal. 2017;20(9):PA920-A921.","journal-title":"Value Heal"},{"key":"1208_CR41","doi-asserted-by":"crossref","unstructured":"Gordon I, Rutherford C, Makarounas-Kirchmann K, Kirchmann M. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System. Diabetes Res Clin Pract (Internet). 2020 Jun;164:108158. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822720304083.","DOI":"10.1016\/j.diabres.2020.108158"},{"issue":"12","key":"1208_CR42","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/dom.13845","volume":"21","author":"I Dicembrini","year":"2019","unstructured":"Dicembrini I, Mannucci E, Monami M, Pala L. Impact of technology on glycaemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Obes Metab (Internet). 2019;21(12):2619\u201325. https:\/\/doi.org\/10.1111\/dom.13845.","journal-title":"Diabetes Obes Metab (Internet)"},{"key":"1208_CR43","unstructured":"NICE. National Institute for Health and Care Excellence. Vol. Published:, NICE guideline. Type 1 diabetes in adults: diagnosis and management; 2022."},{"key":"1208_CR44","unstructured":"Brasil.Minist\u00e9rio da Sa\u00fade. O uso de limiared de custo-efetividade nas decis\u00f5es em sa\u00fade: Recomenda\u00e7\u00e3o da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no SUS (Internet); 2022. Available from: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/pdf\/2022\/20221106_relatorio-uso-de-limiares-de-custo-efetividade-nas-decisoes-em-saude.pdf."},{"key":"1208_CR45","unstructured":"York Health Economics Consortium. Deterministic Sensitivity Analysis (Internet). 2023. Available from: https:\/\/yhec.co.uk\/glossary\/deterministic-sensitivity-analysis\/#:~:text=Deterministic sensitivity analysis (DSA) is parameter or set of parameters."},{"key":"1208_CR46","unstructured":"Staneley H. Near Field Communication: What is NFC & How to Use It. Available from: https:\/\/www.shopify.com\/retail\/near-field-communication."}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-023-01208-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T09:03:44Z","timestamp":1700903024000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-023-01208-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/s13098-023-01208-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3216250\/v1","asserted-by":"object"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,25]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LLPL, NLC and EM are employees of IQVIA. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}